| Literature DB >> 33579975 |
Daniele Merico1, Carl Spickett2, Matthew O'Hara2, Boyko Kakaradov2, Amit G Deshwar2, Phil Fradkin2, Shreshth Gandhi2, Jiexin Gao2, Solomon Grant2, Ken Kron2, Frank W Schmitges2,3, Zvi Shalev2, Mark Sun2, Marta Verby2, Matthew Cahill2, James J Dowling2, Johan Fransson2, Erno Wienholds2,4, Brendan J Frey5.
Abstract
Wilson disease is a recessive genetic disorder caused by pathogenic loss-of-function variants in the ATP7B gene. It is characterized by disrupted copper homeostasis resulting in liver disease and/or neurological abnormalities. The variant NM_000053.3 :c.1934T > G (Met645Arg) has been reported as compound heterozygous, and is highly prevalent among Wilson disease patients of Spanish descent. Accordingly, it is classified as pathogenic by leading molecular diagnostic centers. However, functional studies suggest that the amino acid change does not alter protein function, leading one ClinVar submitter to question its pathogenicity. Here, we used a minigene system and gene-edited HepG2 cells to demonstrate that c.1934T > G causes ~70% skipping of exon 6. Exon 6 skipping results in frameshift and stop-gain, leading to loss of ATP7B function. The elucidation of the mechanistic effect for this variant resolves any doubt about its pathogenicity and enables the development of genetic medicines for restoring correct splicing.Year: 2020 PMID: 33579975 DOI: 10.1038/s41525-020-0123-6
Source DB: PubMed Journal: NPJ Genom Med ISSN: 2056-7944 Impact factor: 8.617